PFC
FLXN

Phocas Financial Corp’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Phocas Financial Corp’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-391,603
Closed -$3.22M – 223
2021
Q2 		$3.22M Buy
391,603
+44,489
+13% +$378K 0.41% 105
2021
Q1 		$3.11M Buy
347,114
+116,490
+51% +$1.34M 0.41% 101
2020
Q4 		$2.66M Buy
+230,624
New +$2.68M 0.41% 104

Other funds holding FLXN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
CC
Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Phocas Financial Corp's FLXN Position: Q3 2021 in Review

Phocas Financial Corp sold out of Flexion Therapeutics, Inc. (FLXN) in Q3 2021, closing a stake of 391,603 shares — an estimated $3.22M sold.

Phocas Financial Corp first reported a position in FLXN in Q4 2020 and held it in 3 quarters. The position peaked at $3.22M in Q2 2021. 145 funds tracked by Wall St. Rank hold FLXN as of Q3 2021.

  • Phocas Financial Corp reported no remaining Flexion Therapeutics, Inc. position as of Q3 2021 after selling out during the quarter.
  • Phocas Financial Corp sold 391,603 Flexion Therapeutics, Inc. shares in Q3 2021, an estimated $3.22M.
  • Phocas Financial Corp first reported a position in Flexion Therapeutics, Inc. in Q4 2020 and held it in 3 quarters.
  • Phocas Financial Corp's Flexion Therapeutics, Inc. position peaked at $3.22M in Q2 2021.
  • 145 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q3 2021.

Based on Phocas Financial Corp's 13F filing for Q3 2021, filed 16 Nov 2021.